CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Rochester, Minnesota, United States and 50 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Rochester, Minnesota, United States and 109 other locations
This research is being done to develop a unique matching process for caregivers of persons living with dementia, such as Alzheimer's disease...
Rochester, Minnesota, United States
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a stic...
Phase 3
Rochester, Minnesota, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal